Solidion Technology Inc. Faces Listing Rule Scrutiny
Ticker: STI · Form: 8-K · Filed: Sep 8, 2025 · CIK: 1881551
Sentiment: neutral
Topics: listing-rules, corporate-action, name-change
TL;DR
Solidion Tech (STI) might be in trouble with the exchange - listing rules issue.
AI Summary
Solidion Technology Inc. filed an 8-K on September 8, 2025, reporting a change in its listing status. The company previously operated as Nubia Brand International Corp. before changing its name on September 2, 2021. The filing indicates potential issues with continued listing rules or standards.
Why It Matters
This filing suggests potential instability or non-compliance with stock exchange rules, which could impact investor confidence and the company's ability to trade publicly.
Risk Assessment
Risk Level: medium — The filing mentions potential delisting or failure to meet continued listing rules, which poses a significant risk to the company's public trading status.
Key Players & Entities
- Solidion Technology Inc. (company) — Registrant
- Nubia Brand International Corp. (company) — Former company name
- September 3, 2025 (date) — Earliest event reported
- September 8, 2025 (date) — Date of report
- September 2, 2021 (date) — Date of name change
FAQ
What specific listing rule or standard has Solidion Technology Inc. failed to satisfy?
The filing does not specify the exact rule or standard that Solidion Technology Inc. has failed to satisfy, only that it is a 'Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard'.
What is the significance of the company's former name, Nubia Brand International Corp.?
Nubia Brand International Corp. was the company's former name before it officially changed to Solidion Technology, Inc. on September 2, 2021.
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report a notice of delisting or failure to satisfy a continued listing rule or standard, and to report changes in directors or officers and compensatory arrangements.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on September 3, 2025.
What is Solidion Technology Inc.'s state of incorporation and fiscal year end?
Solidion Technology Inc. is incorporated in Delaware and its fiscal year ends on December 31.
Filing Stats: 604 words · 2 min read · ~2 pages · Grade level 12.4 · Accepted 2025-09-08 17:01:13
Key Financial Figures
- $0.0001 — registered Common Stock, par value $0.0001 per share STI The Nasdaq Stock Mark
Filing Documents
- ea0256301-8k_solidion.htm (8-K) — 23KB
- 0001213900-25-085599.txt ( ) — 186KB
- sti-20250903.xsd (EX-101.SCH) — 3KB
- sti-20250903_lab.xml (EX-101.LAB) — 33KB
- sti-20250903_pre.xml (EX-101.PRE) — 22KB
- ea0256301-8k_solidion_htm.xml (XML) — 4KB
01 Notice of Delisting or Failure to
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. Information required to be disclosed herein is incorporated by reference from Item 5.02.
02 Departure of Directors or Principal
Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers On September 3, 2025 (the "Effective Date"), Cynthia Ekberg Tsai notified the Board of Directors (the "Board") of Solidion Technology, Inc. (the "Company") of her resignation as a member of the Board, including all committees on which she serves, effective as of the Effective Date. Ms. Ekberg Tsai's resignation did not result from any disagreement with the Company on any matter relating to the Company's operations, policies or practices. As a result of Ms. Ekberg Tsai's resignation, the Company's Audit Committee will be composed of two members. On September 8, 2025, the Company notified The Nasdaq Stock Market, LLC of its non-compliance with Nasdaq Rule 5605(c)(2)(A), which requires that the Audit Committee be composed of three directors. Pursuant to Nasdaq Listing Rule 5605(c)(4), the Company has a cure period to regain compliance by appointing a new independent director to the Audit Committee. The cure period extends until the earlier of the Company's next annual shareholders' meeting or September 3, 2026; provided, however, that if the annual shareholders' meeting occurs no later than March 2, 2026, the Company has until March 2, 2026, to regain compliance. The Company intends to appoint a new independent director to the Audit Committee as soon as practicable within the cure period. 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: September 8, 2025 SOLIDION TECHNOLOGY, INC. By: /s/ Jaymes Winters Name: Jaymes Winters Title: Chief Executive Officer 2